| Literature DB >> 28469096 |
Xiao-Ning Wang1, Chang-Jun Zhang1, Hong-Lu Diao1, Ying Zhang1.
Abstract
BACKGROUND: Excessive reactive oxygen species (ROS) may lead to a number of reproductive diseases such as polycystic ovary syndrome. This study aimed to establish an animal model of ovarian oxidative stress and to assess the protective effect of curcumin against oxidative injury.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28469096 PMCID: PMC5421171 DOI: 10.4103/0366-6999.204927
Source DB: PubMed Journal: Chin Med J (Engl) ISSN: 0366-6999 Impact factor: 2.628
Comparison of the rate of weight gain and index of ovaries in the different groups (n = 10 per group)
| Items | Control group | Curcumin group | |||||
|---|---|---|---|---|---|---|---|
| 0 mg/kg | 100 mg/kg | 150 mg/kg | 200 mg/kg | ||||
| Rate of weight gain (%) | 16.52 ± 9.62 | 11.75 ± 5.88 | 16.29 ± 4.86 | 15.10 ± 5.67 | 13.02 ± 4.19 | 9.62 | 0.614 |
| Index of ovaries (%) | 0.86 ± 0.19 | 0.85 ± 0.15 | 0.96 ± 0.22 | 0.95 ± 0.2 | 1.0 ± 0.24 | 7.12 | 0.521 |
All data were shown as mean ± SD. Comparisons among multiple subgroups were performed using one-way ANOVA. ANOVA: Analysis of variance; SD: Standard deviation.
Comparison of ovarian ROS, MDA, SOD, and GPx levels in different groups (n = 10 per group)
| Items | Control group | Curcumin group | |||||
|---|---|---|---|---|---|---|---|
| 0 mg/kg | 100 mg/kg | 150 mg/kg | 200 mg/kg | ||||
| ROS (IU/mg) | 10.71 ± 0.91 | 11.74 ± 0.65* | 10.64 ± 1.38† | 10.73 ± 0.71† | 10.67 ± 1.38† | 2.655 | 0.045 |
| MDA (nmol/g) | 0.27 ± 0.02 | 0.32 ± 0.02* | 0.28 ± 0.02† | 0.25 ± 0.03† | 0.27 ± 0.04† | 1.254 | 0.032 |
| SOD (U/mg) | 4.51 ± 0.70 | 3.96 ± 0.36* | 4.57 ± 0.68† | 4.49 ± 0.27† | 4.56 ± 0.25† | 2.008 | 0.011 |
| GPx (U/g) | 18.92 ± 1.80 | 17.36 ± 1.63* | 17.98 ± 1.86 | 18.01 ± 1.20 | 18.45 ± 1.65 | 7.968 | 0.041 |
All data were shown as mean ± SD. Comparisons among multiple subgroups were performed using one-way ANOVA. *P<0.05 versus the control group; †P<0.05 versus the 0 mg/kg curcumin treatment group. ROS: Reactive oxygen species; MDA: Malondialdehyde; SOD: Superoxide dismutase; GPx: Glutathione peroxidase; ANOVA: Analysis of variance.
Figure 1Representative images of H and E staining on slices of the right ovary in the control group and 0, 100, 150, or 200 mg/kg curcumin groups (n = 10/group) groups (original magnification ×10). a-e: Ovarian tissue to the naked eye in the five groups. f-j: Representative images of H and E staining on slices of the right ovary in the five groups. Cur: curcumin.
Comparison of the number of follicles per ovary in different groups (n = 10 per group)
| Items | Control group | Curcumin group | |||||
|---|---|---|---|---|---|---|---|
| 0 mg/kg | 100 mg/kg | 150 mg/kg | 200 mg/kg | ||||
| Primordial follicles | 5.96 ± 0.97 | 6.11 ± 0.58 | 6.24 ± 0.23 | 6.57 ± 1.10 | 5.85 ± 0.55 | 9.67 | 0.842 |
| Primary follicles | 3.56 ± 0.35 | 3.78 ± 0.25 | 4.05 ± 0.38 | 3.25 ± 0.58 | 3.09 ± 0.37 | 8.32 | 0.912 |
| Secondary follicles | 4.71 ± 0.85 | 4.25 ± 0.88 | 3.99 ± 0.94 | 4.92 ± 0.94 | 4.23 ± 0.75 | 16.41 | 1.000 |
| Atretic follicles | 5.12 ± 0.84 | 6.34 ± 0.75* | 5.67 ± 0.81† | 5.84 ± 0.98† | 5.72 ± 0.84† | 12.31 | 0.026 |
All data were shown as mean ± SD. Comparisons among multiple subgroups were performed using one-way ANOVA. *P<0.05 versus the control group; †P<0.05 versus the 0 mg/kg curcumin treatment group. ANOVA: Analysis of variance; SD: Standard deviation.
Figure 2BrdU immunohistochemistry of cell proliferation (a-f) and the integrated optical density (g) in the five groups. The brown granules represent the proliferating granular cells. (a) Negative control (control group without anti-BrdU antibody); (b) control group; (c) 0 mg/kg curcumin; (d) 100 mg/kg curcumin; (e) 150 mg/kg curcumin; (f) 200 mg/kg curcumin (a-f, original magnification ×200). (g): integrated optical density in the five groups. n = 10 for each group; *P < 0.05 versus the control group; †P < 0.05 versus the 0 mg/kg curcumin treatment group.
Figure 3p66Shc expression in the five groups. n = 10 for each group; *P < 0.05 versus the control group; †P < 0.05 versus the 0 mg/kg curcumin treatment group. Cur: Curcumin.